24 related articles for article (PubMed ID: 19002462)
1. Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas.
Wu J; Yuan Y; Long Priel DA; Fink D; Peer CJ; Sissung TM; Su YT; Pang Y; Yu G; Butler MK; Mendoza TR; Vera E; Ahmad S; Bryla C; Lindsley M; Grajkowska E; Mentges K; Boris L; Antony R; Garren N; Siegel C; Lollo N; Cordova C; Aboud O; Theeler BJ; Burton EM; Penas-Prado M; Leeper H; Gonzales J; Armstrong TS; Calvo KR; Figg WD; Kuhns DB; Gallin JI; Gilbert MR
Clin Cancer Res; 2021 Jun; 27(12):3298-3306. PubMed ID: 33785481
[TBL] [Abstract][Full Text] [Related]
2. Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published Trials.
Silva RB; Yap C; Carvajal R; Lee SM
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250415
[TBL] [Abstract][Full Text] [Related]
3. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer.
Brock K; Homer V; Soul G; Potter C; Chiuzan C; Lee S
BMC Cancer; 2021 Jul; 21(1):777. PubMed ID: 34225682
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.
McQuade JL; Posada LP; Lecagoonporn S; Cain S; Bassett RL; Patel SP; Hwu WJ; Hwu P; Davies MA; Bedikian AY; Amaria RN
Melanoma Res; 2016 Dec; 26(6):604-608. PubMed ID: 27540836
[TBL] [Abstract][Full Text] [Related]
5. Current research and development of chemotherapeutic agents for melanoma.
Hsan KM; Chen CC; Shyur LF
Cancers (Basel); 2010 Apr; 2(2):397-419. PubMed ID: 24281076
[TBL] [Abstract][Full Text] [Related]
6. The role of taxanes in the treatment of metastatic melanoma.
Gogas H; Bafaloukos D; Bedikian AY
Melanoma Res; 2004 Oct; 14(5):415-20. PubMed ID: 15457099
[TBL] [Abstract][Full Text] [Related]
7. Systemic chemotherapy for the treatment of metastatic melanoma.
Li Y; McClay EF
Semin Oncol; 2002 Oct; 29(5):413-26. PubMed ID: 12407507
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.
Bafaloukos D; Gogas H; Georgoulias V; Briassoulis E; Fountzilas G; Samantas E; Kalofonos Ch; Skarlos D; Karabelis A; Kosmidis P
J Clin Oncol; 2002 Jan; 20(2):420-5. PubMed ID: 11786569
[TBL] [Abstract][Full Text] [Related]
9. The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma.
Yoon C; Papadopoulos NE; Camacho LH; McIntyre S; Alvarado GC; Bedikian AY; Hwu P; Kim KB
Melanoma Res; 2010 Feb; 20(1):43-7. PubMed ID: 19952963
[TBL] [Abstract][Full Text] [Related]
10. Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.
García M; del Muro XG; Tres A; Crespo C; Valladares M; López JJ; Rifà J; Pérez X; Filipovich E; Germà-Lluch JR
Melanoma Res; 2006 Aug; 16(4):365-70. PubMed ID: 16845333
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
Agarwala SS; Kirkwood JM
Cancer; 2003 Jan; 97(1):121-7. PubMed ID: 12491513
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
Larkin JM; Hughes SA; Beirne DA; Patel PM; Gibbens IM; Bate SC; Thomas K; Eisen TG; Gore ME
Br J Cancer; 2007 Jan; 96(1):44-8. PubMed ID: 17146474
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
Kim KB; Hwu WJ; Papadopoulos NE; Bedikian AY; Camacho LH; Ng C; Hernandez IM; Frost AM; Jack MA; Hwu P
Cancer Chemother Pharmacol; 2009 Jun; 64(1):161-7. PubMed ID: 19002462
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
